Health CanadaType I
QUETIAPINE XR : Affected lots may exceed the established acceptable intake limi...
Published: January 7, 2025Recall ID: 76803Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
QUETIAPINE XR
Additional Source Details
| Field | Value |
|---|---|
| N I D | 76803 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/quetiapine-xr-affected-lots-may-exceed-established-acceptable-intake-limit-n-nitroso |
| Issue | Product quality |
| Title | QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP) |
| Product | QUETIAPINE XR |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-01-07 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |